Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news

Show

From To
Dolutegravir regimen highly effective in clinical trial for women

A once-daily regimen containing the potent HIV integrase inhibitor dolutegravir worked better than an older atazanavir-containing regimen – with higher rates of viral suppression both overall and across

Published
07 November 2016
By
Liz Highleyman
Early HIV treatment: mothers say they need time to think

Findings from the first randomised controlled trial to date evaluating postpartum antiretroviral therapy (ART) for women with high CD4 cell counts (over 400 cells/mm3) highlight a critical need

Published
26 July 2016
By
Carole Leach-Lemens
Women with HIV have higher risk of loss to follow-up and death after delivery

Despite the widespread implementation of Option B+ (lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women regardless of CD4 cell count) postpartum HIV-positive women remain at higher risk

Published
26 July 2016
By
Carole Leach-Lemens
Young women treated in very early HIV infection stay HIV negative and preserve immune function

A group of young South African women who were diagnosed in very early infection and immediately given antiretroviral therapy (ART) preserved their CD4 counts and the function

Published
18 July 2016
By
Gus Cairns
Study results provide critical new data to guide HIV prevention and treatment efforts for women and girls

Multiple studies discussed today in an official press briefing at the 21st International AIDS Conference (AIDS 2016) in Durban collectively provide new insights that will help shape future HIV prevention and treatment efforts for women and girls.

Published
18 July 2016
From
AIDS 2016
Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy

Engaging lay counsellors to provide a combination package of evidence-based interventions in Nyanza, Kenya and addressing partner disclosure, as well as pre-treatment education about the benefits of antiretroviral

Published
01 March 2016
By
Carole Leach-Lemens
HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable, researchers find

A group of researchers have cleared up an important question about HIV transmission, in experiments on mice. Although HIV-infected CD4 cells persist in the vagina even on

Published
15 February 2016
By
Gus Cairns
African Americans have highest HIV incidence, lowest rate of consistent care

African Americans in the US have the highest rate of new HIV infections, but black people living with HIV are less likely than white or Latino

Published
08 February 2016
By
Liz Highleyman
How do we maximise global HIV treatment access? IAPAC Care Continuum Guidelines make recommendations

IAPAC, the International Association of Practitioners in AIDS Care, has issued a set of guidelines that aims to establish a common set of best practices to ensure

Published
09 November 2015
By
Gus Cairns
New antiretrovirals and HIV treatment strategies highlighted at ICAAC

Researchers presented findings from several HIV studies at the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) last week in San Diego, USA, including an overview of the START treatment initiation

Published
07 October 2015
By
Liz Highleyman
← First12345...11Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.